The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways
Top Cited Papers
Open Access
- 1 July 2002
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 277 (28), 25226-25232
- https://doi.org/10.1074/jbc.m202489200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- AMP-Activated Protein Kinase Is Activated by the Stimulations of Gq-Coupled ReceptorsBiochemical and Biophysical Research Communications, 2000
- The activation of p38 MAPK by the β‐adrenergic agonist isoproterenol in rat epididymal fat cellsFEBS Letters, 1998
- The search for physiological substrates of MAP and SAP kinases in mammalian cellsTrends in Cell Biology, 1997
- Mammalian AMP-activated Protein Kinase SubfamilyJournal of Biological Chemistry, 1996
- Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinaseFEBS Letters, 1994
- Role of the AMP-activated protein kinase in the cellular stress responseCurrent Biology, 1994
- Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM PatientsDiabetes Care, 1990
- A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesisFEBS Letters, 1987